(2S)-2-[[[5-ethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)piperidin-1-yl]pyrimidin-4-yl]amino]methyl]-4-(3-methoxycarbonylanilino)-4-oxobutanoic acid;1,1,1,4,4,4-hexafluorobutane-2,3-dione

C36H39F6N7O7 — CID 91342131

IUPAC(2S)-2-[[[5-ethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)piperidin-1-yl]pyrimidin-4-yl]amino]methyl]-4-(3-methoxycarbonylanilino)-4-oxobutanoic acid;1,1,1,4,4,4-hexafluorobutane-2,3-dione
SMILESCCc1c(NC[C@H](CC(=O)Nc2cccc(C(=O)OC)c2)C(=O)O)ncnc1N1CCC(c2ccc3c(n2)NCCC3)CC1.O=C(C(=O)C(F)(F)F)C(F)(F)F
InChIInChI=1S/C32H39N7O5.C4F6O2/c1-3-25-29(34-18-23(31(41)42)17-27(40)37-24-8-4-6-22(16-24)32(43)44-2)35-19-36-30(25)39-14-11-20(12-15-39)26-10-9-21-7-5-13-33-28(21)38-26;5-3(6,7)1(11)2(12)4(8,9)10/h4,6,8-10,16,19-20,23H,3,5,7,11-15,17-18H2,1-2H3,(H,33,38)(H,37,40)(H,41,42)(H,34,35,36);/t23-;/m0./s1
InChIKeyXFWOZJBJSMTHBY-BQAIUKQQSA-N
MW795.74 g/mol
LogP5.35
Rot. Bonds12

About (2S)-2-[[[5-ethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)piperidin-1-yl]pyrimidin-4-yl]amino]methyl]-4-(3-methoxycarbonylanilino)-4-oxobutanoic acid;1,1,1,4,4,4-hexafluorobutane-2,3-dione

(2S)-2-[[[5-ethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)piperidin-1-yl]pyrimidin-4-yl]amino]methyl]-4-(3-methoxycarbonylanilino)-4-oxobutanoic acid;1,1,1,4,4,4-hexafluorobutane-2,3-dione (PubChem CID 91342131) has the molecular formula C36H39F6N7O7 and a molecular weight of 795.74 g/mol. Its IUPAC name is (2S)-2-[[[5-ethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)piperidin-1-yl]pyrimidin-4-yl]amino]methyl]-4-(3-methoxycarbonylanilino)-4-oxobutanoic acid;1,1,1,4,4,4-hexafluorobutane-2,3-dione.

Molecular Properties

Compound Name(2S)-2-[[[5-ethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)piperidin-1-yl]pyrimidin-4-yl]amino]methyl]-4-(3-methoxycarbonylanilino)-4-oxobutanoic acid;1,1,1,4,4,4-hexafluorobutane-2,3-dione
PubChem CID91342131
Molecular FormulaC36H39F6N7O7
Molecular Weight795.74 g/mol
Exact Mass795.28
IUPAC Name(2S)-2-[[[5-ethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)piperidin-1-yl]pyrimidin-4-yl]amino]methyl]-4-(3-methoxycarbonylanilino)-4-oxobutanoic acid;1,1,1,4,4,4-hexafluorobutane-2,3-dione
SMILESCCc1c(NC[C@H](CC(=O)Nc2cccc(C(=O)OC)c2)C(=O)O)ncnc1N1CCC(c2ccc3c(n2)NCCC3)CC1.O=C(C(=O)C(F)(F)F)C(F)(F)F
InChIInChI=1S/C32H39N7O5.C4F6O2/c1-3-25-29(34-18-23(31(41)42)17-27(40)37-24-8-4-6-22(16-24)32(43)44-2)35-19-36-30(25)39-14-11-20(12-15-39)26-10-9-21-7-5-13-33-28(21)38-26;5-3(6,7)1(11)2(12)4(8,9)10/h4,6,8-10,16,19-20,23H,3,5,7,11-15,17-18H2,1-2H3,(H,33,38)(H,37,40)(H,41,42)(H,34,35,36);/t23-;/m0./s1
InChIKeyXFWOZJBJSMTHBY-BQAIUKQQSA-N
XLogP5.35
TPSA192.81 Ų
H-Bond Donors4
H-Bond Acceptors12
Rotatable Bonds12
Heavy Atoms56
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500795.74
LogP ≤ 55.35
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_one_A(321)', 'substructure': 'N/A'}, {'alert_name': 'diketo_group', 'substructure': 'N/A'}

Analyze (2S)-2-[[[5-ethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)piperidin-1-yl]pyrimidin-4-yl]amino]methyl]-4-(3-methoxycarbonylanilino)-4-oxobutanoic acid;1,1,1,4,4,4-hexafluorobutane-2,3-dione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S)-2-[[[5-ethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)piperidin-1-yl]pyrimidin-4-yl]amino]methyl]-4-(3-methoxycarbonylanilino)-4-oxobutanoic acid;1,1,1,4,4,4-hexafluorobutane-2,3-dione?
The IUPAC name of (2S)-2-[[[5-ethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)piperidin-1-yl]pyrimidin-4-yl]amino]methyl]-4-(3-methoxycarbonylanilino)-4-oxobutanoic acid;1,1,1,4,4,4-hexafluorobutane-2,3-dione (CID 91342131) is (2S)-2-[[[5-ethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)piperidin-1-yl]pyrimidin-4-yl]amino]methyl]-4-(3-methoxycarbonylanilino)-4-oxobutanoic acid;1,1,1,4,4,4-hexafluorobutane-2,3-dione.
What is the SMILES notation for (2S)-2-[[[5-ethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)piperidin-1-yl]pyrimidin-4-yl]amino]methyl]-4-(3-methoxycarbonylanilino)-4-oxobutanoic acid;1,1,1,4,4,4-hexafluorobutane-2,3-dione?
The canonical SMILES for (2S)-2-[[[5-ethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)piperidin-1-yl]pyrimidin-4-yl]amino]methyl]-4-(3-methoxycarbonylanilino)-4-oxobutanoic acid;1,1,1,4,4,4-hexafluorobutane-2,3-dione is CCc1c(NC[C@H](CC(=O)Nc2cccc(C(=O)OC)c2)C(=O)O)ncnc1N1CCC(c2ccc3c(n2)NCCC3)CC1.O=C(C(=O)C(F)(F)F)C(F)(F)F.
What is the InChIKey of (2S)-2-[[[5-ethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)piperidin-1-yl]pyrimidin-4-yl]amino]methyl]-4-(3-methoxycarbonylanilino)-4-oxobutanoic acid;1,1,1,4,4,4-hexafluorobutane-2,3-dione?
The InChIKey is XFWOZJBJSMTHBY-BQAIUKQQSA-N. The full InChI is InChI=1S/C32H39N7O5.C4F6O2/c1-3-25-29(34-18-23(31(41)42)17-27(40)37-24-8-4-6-22(16-24)32(43)44-2)35-19-36-30(25)39-14-11-20(12-15-39)26-10-9-21-7-5-13-33-28(21)38-26;5-3(6,7)1(11)2(12)4(8,9)10/h4,6,8-10,16,19-20,23H,3,5,7,11-15,17-18H2,1-2H3,(H,33,38)(H,37,40)(H,41,42)(H,34,35,36);/t23-;/m0./s1.
What are the key properties of (2S)-2-[[[5-ethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)piperidin-1-yl]pyrimidin-4-yl]amino]methyl]-4-(3-methoxycarbonylanilino)-4-oxobutanoic acid;1,1,1,4,4,4-hexafluorobutane-2,3-dione?
(2S)-2-[[[5-ethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)piperidin-1-yl]pyrimidin-4-yl]amino]methyl]-4-(3-methoxycarbonylanilino)-4-oxobutanoic acid;1,1,1,4,4,4-hexafluorobutane-2,3-dione has a molecular weight of 795.74 g/mol, XLogP of 5.35, 12 rotatable bonds, 4 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-2-[[[5-ethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)piperidin-1-yl]pyrimidin-4-yl]amino]methyl]-4-(3-methoxycarbonylanilino)-4-oxobutanoic acid;1,1,1,4,4,4-hexafluorobutane-2,3-dione is sourced from PubChem (CID 91342131), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).